168 related articles for article (PubMed ID: 26206467)
1. Cardiac sarcoidosis with visually normal wall motion: role of cardiac MRI, FDG PET, and strain echocardiography.
Saeed IM; Coggins T; Main ML; Bateman TM
Eur Heart J Cardiovasc Imaging; 2015 Nov; 16(11):1275. PubMed ID: 26206467
[No Abstract] [Full Text] [Related]
2. [Active cardiac sarcoidosis: Diagnosis and adjustment of therapy with FDG PET/CT].
Philippe L; Casset-Senon D; Lorette G; Diot P; Cosnay P
Presse Med; 2015 Jun; 44(6 Pt 1):690-2. PubMed ID: 25534464
[No Abstract] [Full Text] [Related]
3. Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
Orii M; Hirata K; Tanimoto T; Ota S; Shiono Y; Yamano T; Matsuo Y; Ino Y; Yamaguchi T; Kubo T; Tanaka A; Akasaka T
Heart Rhythm; 2015 Dec; 12(12):2477-85. PubMed ID: 26111805
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
[TBL] [Abstract][Full Text] [Related]
5. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.
Ohira H; Tsujino I; Ishimaru S; Oyama N; Takei T; Tsukamoto E; Miura M; Sakaue S; Tamaki N; Nishimura M
Eur J Nucl Med Mol Imaging; 2008 May; 35(5):933-41. PubMed ID: 18084757
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis.
Yokoyama R; Miyagawa M; Okayama H; Inoue T; Miki H; Ogimoto A; Higaki J; Mochizuki T
Int J Cardiol; 2015 Sep; 195():180-7. PubMed ID: 26043154
[TBL] [Abstract][Full Text] [Related]
7. Combination of 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis.
Ishimaru S; Tsujino I; Sakaue S; Oyama N; Takei T; Tsukamoto E; Tamaki N; Nishimura M
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):234-5. PubMed ID: 16315788
[No Abstract] [Full Text] [Related]
8. Multimodality evaluation of cardiac sarcoidosis.
Manabe O; Oyama-Manabe N; Ohira H; Tsutsui H; Tamaki N
J Nucl Cardiol; 2012 Jun; 19(3):621-4. PubMed ID: 22422295
[No Abstract] [Full Text] [Related]
9. Incremental Prognostic Value of Global Longitudinal Strain and 18F-Fludeoxyglucose Positron Emission Tomography in Patients With Systemic Sarcoidosis.
Sperry BW; Ibrahim A; Negishi K; Negishi T; Patel P; Popović ZB; Culver D; Brunken R; Marwick TH; Tamarappoo B
Am J Cardiol; 2017 May; 119(10):1663-1669. PubMed ID: 28343598
[TBL] [Abstract][Full Text] [Related]
10. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
[TBL] [Abstract][Full Text] [Related]
11. Predictors of cardiac sarcoidosis using commonly available cardiac studies.
Freeman AM; Curran-Everett D; Weinberger HD; Fenster BE; Buckner JK; Gottschall EB; Sauer WH; Maier LA; Hamzeh NY
Am J Cardiol; 2013 Jul; 112(2):280-5. PubMed ID: 23602692
[TBL] [Abstract][Full Text] [Related]
12. Sarcoidosis manifesting as cardiac sarcoidosis and massive splenomegaly.
Kawano S; Kato J; Kawano N; Yoshimura Y; Masuyama H; Fukunaga T; Shimao Y; Mihara K; Ueda A; Toyoda K; Imamura T; Kitamura K
Intern Med; 2012; 51(1):65-9. PubMed ID: 22214625
[TBL] [Abstract][Full Text] [Related]
13. Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis.
Manabe O; Ohira H; Yoshinaga K; Sato T; Klaipetch A; Oyama-Manabe N; Ito YM; Tsujino I; Nishimura M; Tamaki N
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1558-66. PubMed ID: 23715906
[TBL] [Abstract][Full Text] [Related]
14. Assessment of cardiac sarcoidosis with advanced imaging modalities.
Orii M; Imanishi T; Akasaka T
Biomed Res Int; 2014; 2014():897956. PubMed ID: 25250336
[TBL] [Abstract][Full Text] [Related]
15. Utility of multimodal cardiac imaging with PET/MRI in cardiac sarcoidosis: implications for diagnosis, monitoring and treatment.
Schneider S; Batrice A; Rischpler C; Eiber M; Ibrahim T; Nekolla SG
Eur Heart J; 2014 Feb; 35(5):312. PubMed ID: 23975480
[No Abstract] [Full Text] [Related]
16. Cardiac sarcoidosis diagnosed by multimodality imaging.
Fujikura K; Garcia MJ
Echocardiography; 2017 Sep; 34(9):1374-1375. PubMed ID: 28752531
[TBL] [Abstract][Full Text] [Related]
17. MRI and FDG PET/CT imaging manifestations of cardiac sarcoidosis.
Lu Y; Sweiss NJ
Clin Nucl Med; 2015 Dec; 40(12):973-4. PubMed ID: 26544904
[TBL] [Abstract][Full Text] [Related]
18. Cardiac sarcoidosis mimicking non-ST-elevation myocardial infarction.
Uijlings R; Balt JC; Boom P; Wever E
J Cardiovasc Med (Hagerstown); 2012 Apr; 13(4):277-80. PubMed ID: 20508527
[No Abstract] [Full Text] [Related]
19. The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.
Paz YE; Bokhari S
Int J Cardiovasc Imaging; 2014 Feb; 30(2):431-8. PubMed ID: 24293048
[TBL] [Abstract][Full Text] [Related]
20. Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis.
Manabe O; Yoshinaga K; Ohira H; Sato T; Tsujino I; Yamada A; Oyama-Manabe N; Masuda A; Magota K; Nishimura M; Tamaki N
Ann Nucl Med; 2014 Aug; 28(7):656-63. PubMed ID: 24889126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
